Westlake Chemical Corp. (NYSE:WLK) belongs to Basic Materials sector. Its net profit margin is 14.80% and weekly performance is -1.42%. On last trading day company shares ended up $65.39. Westlake Chemical Corp. (NYSE:WLK) distance from 50-day simple moving average (SMA50) is -7.48%. On June 1, Westlake Chemical Corp. (NYSE:WLK) announced today that it has acquired INEOS ChlorVinyls Holdings B.V.’s 35.7% interest in Suzhou Huasu Plastics Co., Ltd. (SHPC), a polyvinyl chloride (PVC) resin and downstream fabrication joint venture based near Shanghai, China. Westlake now owns a 95% interest in this joint venture.
Lockheed Martin Corporation (NYSE:LMT) shares advanced 1.07% in last trading session and ended the day at $194.19. LMT Gross Margin is 11.70% and its return on assets is 9.40%. Lockheed Martin Corporation (NYSE:LMT) quarterly performance is -2.33%. Lockheed Martin Corporation (NYSE:LMT) is the leading candidate to buy United Technologies Corp’s Sikorsky helicopter unit in a deal that could value the business at more than $8 billion, a source familiar with the situation said on Friday.
On 10 July, Meritor, Inc. (NYSE:MTOR) shares advanced 0.76% and was closed at $13.30. MTOR EPS growth in last 5 year was 17.90%. Meritor, Inc. (NYSE:MTOR) year to date (YTD) performance is -12.21%. Meritor, Inc. (NYSE:MTOR) announced that it has purchased the majority of the assets at the Sypris Solutions, Inc. manufacturing facility in Morganton, North Carolina. The facility currently manufactures trailer axle beams, and machines carriers and differentials for Meritor, in addition to producing light vehicle components for other customers.
Cisco Systems, Inc. (NASDAQ:CSCO) ended the last trading day at $27.28. Company weekly volatility is calculated as 1.58% and price to cash ratio as 2.55. Cisco Systems, Inc. (NASDAQ:CSCO) showed a weekly performance of -0.18%. Cisco Systems, Inc. (NASDAQ:CSCO) will invest $1 billion to spur digital economic growth in UK. The investment will include a combination of job creation and education programs, startup and venture capital investments, and accelerated investing in cybersecurity solutions.
Opko Health, Inc. (NYSE:OPK) shares moved down -0.06% in last trading session and ended the day at $16.55. OPK Gross Margin is 53.60% and its return on assets is -18.10%. Opko Health, Inc. (NYSE:OPK) quarterly performance is 16.14%. OPKO Health, Inc. (NYSE:OPK) has completed enrollment in the single pivotal Phase 3 trial of its long acting human growth hormone (hGH-CTP) in growth hormone deficient (GHD) adults. The trial is designed to evaluate the safety and efficacy of hGH-CTP with a primary endpoint of superiority compared to placebo in decreasing fat mass in adults with GHD. The trial is a randomized, double-blind, placebo-controlled, multi-center, global study in adults with GHD.